Baltazar, Romero A.
HRN: 27 96 47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFTAZIDIME 1GM (VIAL)
10/18/2025
10/24/2025
IV
1gm
Q8
Cap MR; Hydropneumothorax
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes